Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
29 Aug 2024 |
TM01 |
Termination of appointment of Michael Albert Salako as a director on 26 July 2024
|
|
|
02 Jul 2024 |
TM02 |
Termination of appointment of Taylor Wessing Secretaries Limited as a secretary on 2 July 2024
|
|
|
17 Jun 2024 |
CS01 |
Confirmation statement made on 4 May 2024 with no updates
|
|
|
29 Feb 2024 |
AA |
Total exemption full accounts made up to 31 May 2023
|
|
|
11 May 2023 |
CS01 |
Confirmation statement made on 4 May 2023 with no updates
|
|
|
09 Aug 2022 |
AA |
Total exemption full accounts made up to 31 May 2022
|
|
|
21 Jul 2022 |
AP01 |
Appointment of Dr John William Beadle as a director on 4 July 2022
|
|
|
18 May 2022 |
CS01 |
Confirmation statement made on 4 May 2022 with updates
|
|
|
26 Nov 2021 |
AA |
Accounts for a dormant company made up to 31 May 2021
|
|
|
23 Nov 2021 |
CH01 |
Director's details changed for Dr Andrew Douglas Moore on 22 November 2021
|
|
|
23 Nov 2021 |
AP01 |
Appointment of Dr Andrew Douglas Moore as a director on 22 November 2021
|
|
|
19 Nov 2021 |
PSC07 |
Cessation of Eugene Park as a person with significant control on 6 October 2021
|
|
|
18 Nov 2021 |
SH01 |
Statement of capital following an allotment of shares on 19 October 2021
|
|
|
15 Nov 2021 |
SH02 |
Sub-division of shares on 18 October 2021
|
|
|
15 Nov 2021 |
MA |
Memorandum and Articles of Association
|
|
|
15 Nov 2021 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
03 Nov 2021 |
MA |
Memorandum and Articles of Association
|
|
|
03 Nov 2021 |
RESOLUTIONS |
Resolutions
-
RES12 ‐
Resolution of varying share rights or name
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
03 Nov 2021 |
SH08 |
Change of share class name or designation
|
|
|
28 Oct 2021 |
AP01 |
Appointment of Dr Thomas Paul Wallace as a director on 28 October 2021
|
|
|
28 Oct 2021 |
AP01 |
Appointment of Dr Michale Bouskila-Chubb as a director on 28 October 2021
|
|
|
25 Oct 2021 |
AP01 |
Appointment of Dr. Michael Albert Salako as a director on 18 October 2021
|
|
|
25 Oct 2021 |
SH01 |
Statement of capital following an allotment of shares on 6 October 2021
|
|
|
30 Sep 2021 |
AD01 |
Registered office address changed from Moneta Building Babraham Research Campus Cambridge CB22 3AT England to C/O Milner Therapeutics Institute Jeffrey Cheah Biomedical Centre Puddicombe Way Cambridge Cambridgeshire CB2 0AW on 30 September 2021
|
|
|
16 Jul 2021 |
TM01 |
Termination of appointment of Eugene Park as a director on 16 July 2021
|
|